Over the past few years, businesses are digitizing their operations on vast scale, and pharmaceutical sector is no exception to this. Digitization comes with its own set of challenges such as gathering massive data, analyzing it and using the analyzed data to decipher complicated data challenges. Artificial intelligence (AI) has the potential to overcome these challenges. Organizations are using AI technology to handle immense volumes of data with better automation, generate data driven insights, mimic human intelligence and much more.
The wide range of benefits offered by AL is increasing its adoption in almost every business. Today, many leading pharma companies are leveraging AI technology to enhance their processes of manufacturing, drug research and development. A news portal predicts that nearly 50% of global healthcare companies will be adopting AI technologies by 2025.
But why are pharma companies increasingly adopting AI? What is the role of AI in drug discovery?
Let’s get to know through this article. Read on to understand the role of AI in drug discovery, how AI is helping modernize the traditional drug research method and how the overall drug discovery process has become faster, better and cheaper with AI technology.